Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Tumori
|
February 19, 2024
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors?
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, et al.
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors
Orietta Giuliani, Silvia Mancini, Donella Puliti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2003
Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
Laura Ridolfi, Ruggero Ridolfi, Angela Riccobon, et al.
Epidemiologia E Prevenzione
|
September 11, 2007
Screening for colorectal cancer in Italy: 2005 survey
Manuel Zorzi, Alessandra Barca, Fabio Falcini, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 18, 2016
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study
Paola Garutti, Paolo Cristiani, Gian P Fantin, et al.
Tumori
|
October 26, 2013
Estimates of cancer burden in Emilia-Romagna
Fabio Falcini, Silvia Mancini, Alessandra Ravaioli, et al.
Breast Cancer Research and Treatment
|
March 5, 2008
Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening
Lauro Bucchi, Flavia Foca, Alessandra Ravaioli, et al.
Breast (Edinburgh, Scotland)
|
March 17, 2026
External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data
Silvia Mancini, Fabiola Giudici, Lauro Bucchi, et al.
Frontiers in Oncology
|
September 25, 2020
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma <i>in situ</i>
Alberto Farolfi, Elisabetta Petracci, Luigi Serra, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Tumori
|
February 19, 2024
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors?
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, et al.
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors
Orietta Giuliani, Silvia Mancini, Donella Puliti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2003
Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
Laura Ridolfi, Ruggero Ridolfi, Angela Riccobon, et al.
Epidemiologia E Prevenzione
|
September 11, 2007
Screening for colorectal cancer in Italy: 2005 survey
Manuel Zorzi, Alessandra Barca, Fabio Falcini, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 18, 2016
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study
Paola Garutti, Paolo Cristiani, Gian P Fantin, et al.
Tumori
|
October 26, 2013
Estimates of cancer burden in Emilia-Romagna
Fabio Falcini, Silvia Mancini, Alessandra Ravaioli, et al.
Breast Cancer Research and Treatment
|
March 5, 2008
Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening
Lauro Bucchi, Flavia Foca, Alessandra Ravaioli, et al.
Breast (Edinburgh, Scotland)
|
March 17, 2026
External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data
Silvia Mancini, Fabiola Giudici, Lauro Bucchi, et al.
Frontiers in Oncology
|
September 25, 2020
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma <i>in situ</i>
Alberto Farolfi, Elisabetta Petracci, Luigi Serra, et al.
Page
of 9